China OKs 1st homegrown vaccine said to be 79 3% effective - International - World ahram.org.eg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ahram.org.eg Daily Mail and Mail on Sunday newspapers.
1 shares
The Zaka emergency service says 157 Israelis were found dead in their homes, days after their deaths, in 2020, marking a 20% rise from 2019.
The organization notes, in a statement: “Most, but not all, were elderly people living alone, with no-one to care for them or check on their well-being – a situation exacerbated by the isolation and lockdowns that characterized 2020. In every case, these were people living alone who died alone. It was only when neighbors noticed the horrible stench emanating from the apartment, or water flowing from a bathroom, that someone remembered that they had not been seen in a while – and called the police.”
HEADLINES & GLOBAL NEWS
By
Dec 31, 2020 06:01 AM EST
The US has rolled out its Pfizer and Moderna COVID-19 vaccines; now, the Chinese Sinopharm has conditional approval. Unlike other pharma, this is Chinese made and state-owned.
Health regulators in China last Thursday have indicated conditional approval for the use of coronavirus vaccine created by the state-controlled pharma.
In China, the two-dose vaccine is approved for general distribution. Its approval comes as a project 50-million Chinese will be vaccinated. Just in time for the start of the Lunar New Year holiday in February, as early release vaccines inoculate more, reported AP News.
Even if a conditional approval allows distribution for use, the vaccine is not yet fully complete. It might have side effects for those opting to take it; whatever side effects that are detected must be reported when sold. Chen Shifei, the deputy commissioner of the National Medical Products Administration, said it in a press
Updated Dec 31, 2020 | 13:05 IST
Sinopharm is one of at least five Chinese developers that are currently developing vaccines for the novel coronavirus. They plan to vaccinate 50 million people in China by mid-February. China approves first COVID vaccine as Sinopharm receives conditional emergency use authorization | Photo Credit: iStock Images
New Delhi: China has approved the first vaccine against COVID-19, the disease caused by the novel coronavirus. The vaccine candidate approved by China is the Sinopharm s COVID vaccine, homegrown in China itself.
The approvals granted to Sinopharm are conditional, news reports have confirmed.
Chen Shifei, the deputy commissioner of China s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night, news agency PTI reported.
Final proof of its effectiveness will depend on publication of more data.
Advertisement
Sinopharm is one of at least five Chinese developers in a global race to create vaccines for the disease that has killed more than 1.8 million people worldwide.
In addition to the emergency vaccinations already underway, China plans to start vaccinating high-risk populations, including seniors and people with existing chronic illnesses. Officials did not say what percentage of the population they would vaccinate in China.
“This is different in every country, but the general thinking is that it has to reach 60% to protect the entire population,” said Zeng Yixin, vice minister of the National Health Commission.